IP Library Granted Patent US 12,311,076
Granted Patent B1
US 12,311,076 · App. 16/433,668 · Granted May 27, 2025

Demineralized bone matrix composition with enhanced osteoinductivity and osteoconductivity

Inventors: Frank Vizesi (Carlsbad, CA); Scott David Boden (Carlsbad, CA); Tyler Paul Lipschultz (Carlsbad, CA); Michelle Esplago Pacer (Carlsbad, CA); Doo Wan Kim (Carlsbad, CA)
Assignee: Seaspine, Inc.
A61L27/3608A61L27/3691A61L2430/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,311,076
App. No.
16/433,668
Granted
May 27, 2025
Kind
B1
Abstract

An osteoinductive and osteoconductive composition including DBM fibers having multiple geometries, as well as a method of producing the same are disclose. For example, such a method may include: obtaining bone tissue; cleaning the bone tissue obtained with a plurality of washes; milling the cleaned bone tissue into a plurality of fibers of two or more geometries including a long wide fiber, a long narrow fiber, a short wide fiber, and a short narrow fiber; demineralizing the plurality of fibers of two or more geometries to expose one or more biologically active components; and neutralizing the plurality of demineralized fibers of two or more geometries resulting in demineralized bone matrix.

Claims (21)

1. A method of producing an osteoinductive and osteoconductive composition for in vivo use, the method comprising:

obtaining bone tissue;

cleaning the bone tissue obtained with a plurality of washes;

milling the cleaned bone tissue into a plurality of fibers, wherein each fiber of the plurality of fibers has a geometry selected from:

a long wide fiber, wherein the long wide fiber has a length of about 10 mm or greater and a width between about 0.6 mm and about 1.0 mm,

a long narrow fiber, wherein the long narrow fiber has a length of greater than about 10 mm and a width between about 0.2 mm and about 0.6 mm,

a short wide fiber, wherein the short wide fiber has a length of less than about 10 mm and a width between about 0.6 mm and about 1.0 mm, or

a short narrow fiber, wherein the short narrow fiber has a length of less than about 10 mm and a width between about 0.2 mm and about 0.6 mm;

demineralizing the plurality of fibers to expose one or more biologically active components;

selecting a mixture of fibers from the plurality of fibers, wherein the mixture consists of a ratio of long wide fibers to long narrow fibers;

combining the mixture of fibers to yield an osteoinductive and osteoconductive composition having osteoinductive properties and osteoconductive properties, wherein:

the ratio comprises a larger proportion of long wide fibers to impart greater osteoinductive properties to the osteoinductive and osteoconductive composition, or

the ratio comprises a larger proportion of long narrow fibers to impart greater osteoconductive properties to the osteoinductive and osteoconductive composition.

2. The method of claim 1 , wherein the long wide fiber has a length between about 10 mm and about 50 mm, and a width of about 0.8 mm.

3. The method of claim 1 , wherein the long narrow fiber has a length between about 10 mm and about 50 mm and a width of about 0.4 mm.

4. The method of claim 1 , wherein the short wide fiber has a length of less than about 10 mm and a width of about 0.8 mm.

5. The method of claim 1 , wherein the short narrow fiber has a length of less than about 10 mm and a width of about 0.4 mm.

6. The method of claim 1 , wherein the ratio of the long wide fibers to the long narrow fibers is about 65:35.

7. The method of claim 1 , further comprising freeze-drying the plurality of demineralized fibers of two or more geometries.

8. The method of claim 1 , wherein demineralizing the plurality of fibers of two or more geometries includes treating the plurality of fibers with a hydrochloric acid treatment.

9. The method of claim 8 , further comprising neutralizing the plurality of demineralized fibers of two or more geometries resulting in demineralized bone matrix.

Assignments (13)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 9, 2025
From: SEASPINE LLC
To: ORTHOFIX MEDICAL INC.
Reel/Frame 073931/0214 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 9, 2025
From: ORTHOFIX MEDICAL INC.
To: SEASPINE ORTHOPEDICS CORPORATION
Reel/Frame 073931/0145 →
CHANGE OF NAME Recorded Oct 8, 2025
From: SEASPINE, INC.
To: SEASPINE LLC
Reel/Frame 073052/0150 →
RELEASE OF SECURITY INTEREST Recorded Nov 12, 2024
From: BLUE TORCH FINANCE LLC
To: ISOTIS ORTHOBIOLOGICS, INC.; ORTHOFIX US, LLC; SEASPINE, INC.; SEASPINE ORTHOPEDICS CORPORATION; SPINAL KINETICS LLC; THEKEN SPINE, LLC
Reel/Frame 069358/0110 →
SECURITY INTEREST Recorded Nov 8, 2024
From: ORTHOFIX MEDICAL INC.; ORTHOFIX US LLC; SPINAL KINETICS LLC; SEASPINE ORTHOPEDICS CORPORATION; SEASPINE, INC.; ISOTIS ORTHOBIOLOGICS, INC.; THEKEN SPINE, LLC
To: OXFORD FINANCE LLC, AS AGENT
Reel/Frame 069332/0761 →
RELEASE OF SECURITY INTEREST Recorded Nov 7, 2024
From: JPMORGAN CHASE BANK, N.A.
To: SEASPINE ORTHOPEDICS CORPORATION; SEASPINE, INC.; ISOTIS ORTHOBIOLOGICS, INC.; THEKEN SPINE, LLC
Reel/Frame 069323/0561 →
SECURITY INTEREST Recorded Jan 10, 2024
From: SEASPINE, INC.
To: BLUE TORCH FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 066257/0718 →
SECURITY INTEREST Recorded Feb 21, 2023
From: SEASPINE ORTHOPEDICS CORPORATION; SEASPINE, INC.; ISOTIS ORTHOBIOLOGICS, INC.; THEKEN SPINE, LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE ASSISTANT
Reel/Frame 062819/0650 →
RELEASE OF SECURITY INTEREST Recorded Jan 9, 2023
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: SEASPINE HOLDINGS CORPORATION; SEASPINE ORTHOPEDICS CORPORATION; SEASPINE, INC.; ISOTIS, INC.; SEASPINE SALES LLC; ISOTIS ORTHOBIOLOGICS, INC.; THEKEN SPINE, LLC; SEASPINE ORTHOPEDICS INTERMEDIATECO, INC.; 7D SURGICAL USA INC.
Reel/Frame 062336/0593 →
SECOND AMENDMENT TO PATENT SECURITY AGREEMENT Recorded Jul 18, 2022
From: SEASPINE HOLDINGS CORPORATION; SEASPINE ORTHOPEDICS CORPORATION; SEASPINE, INC.; ISOTIS, INC.; SEASPINE SALES LLC; ISOTIS ORTHOBIOLOGICS, INC.; THEKEN SPINE, LLC; SEASPINE ORTHOPEDICS INTERMEDIATECO, INC.; 7D SURGICAL USA INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 060715/0395 →
SECURITY INTEREST Recorded Oct 27, 2021
From: SEASPINE HOLDINGS CORPORATION; SEASPINE ORTHOPEDICS CORPORATION; SEASPINE, INC.; ISOTIS, INC.; SEASPINE SALES LLC; ISOTIS ORTHOBIOLOGICS, INC.; THEKEN SPINE, LLC; SEASPINE ORTHOPEDICS INTERMEDIATECO, INC.; 7D SURGICAL USA INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 057941/0609 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 13, 2019
From: BODEN, SCOTT
To: SEASPINE, INC.
Reel/Frame 050365/0373 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 13, 2019
From: VIZESI, FRANK; LIPSCHULTZ, TYLER PAUL; PACER, MICHELLE ESPLAGO; KIM, DOO WAN
To: SEASPINE, INC.
Reel/Frame 050365/0381 →